Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb 16;30(159):200293.
doi: 10.1183/16000617.0293-2020. Print 2021 Mar 31.

Cystic fibrosis-related diabetes and lung disease: an update

Affiliations
Review

Cystic fibrosis-related diabetes and lung disease: an update

Bernadette J Prentice et al. Eur Respir Rev. .

Abstract

The development of cystic fibrosis-related diabetes (CFRD) often leads to poorer outcomes in patients with cystic fibrosis including increases in pulmonary exacerbations, poorer lung function and early mortality. This review highlights the many factors contributing to the clinical decline seen in patients diagnosed with CFRD, highlighting the important role of nutrition, the direct effect of hyperglycaemia on the lungs, the immunomodulatory effects of high glucose levels and the potential role of genetic modifiers in CFRD.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: B.J. Prentice reports other funding from Vertex/TSANZ fellowship, NHMRC postgraduate scholarship, and the Australian Government Research Training Program scholarship, during the conduct of the study. Conflict of interest: A. Jaffe has nothing to disclose. Conflict of interest: S. Hameed reports grants from National Health and Medical Research Council of Australia, Australasian Cystic Fibrosis Research Trust, Regional Diabetes Support Scheme, Sydney Children's Hospital Foundation, and Australasian Pediatric Endocrine Care Grant from Pfizer, and non-financial support from Novo Nordisk, Medtronic and Abbott Diagnostics, during the conduct of the study. Conflict of interest: C.F. Verge reports grants from National Health and Medical Research Council of Australia, Australasian Cystic Fibrosis Research Trust, Regional Diabetes Support Scheme, Sydney Children's Hospital Foundation and Australasian Pediatric Endocrine Care Grant from Pfizer, and non-financial support from Novo Nordisk, Medtronic and Abbott Diagnostics, during the conduct of the study. Conflict of interest: S. Waters has nothing to disclose. Conflict of interest: J. Widger has nothing to disclose.

Figures

FIGURE 1
FIGURE 1
Schematic diagram of airway surface liquid (ASL) glucose homeostasis. a) In health, ASL has a tightly regulated glucose gradient in which minimal glucose (black triangles) is present. ASL hydration is supported by the CFTR protein which is situated on the apical plasma membrane and transports Cl and HCO3 ions into the ASL. ASL glucose is transported to the site of intracellular glucose metabolism by GLUT transporters and there is minimal passive diffusion across tight paracellular junctions. b) In the setting of CFRD, there are changes in ASL with reduced and inflamed ASL, with an increased number of bacteria seen (crossed circles). Paracellular junctions leak glucose into the ASL. Despite initial upregulation of apical GLUT transporters, there is net increase in movement of glucose towards the ASL and an increased level of glucose is seen in the ASL. CFRD: cystic fibrosis-related diabetes; CFTR: cystic fibrosis transmembrane conductance regulator; GLUT: glucose transporter.
FIGURE 2
FIGURE 2
Graphical representation of potential mechanisms involved in the loss of lung function associated with the development of cystic fibrosis-related diabetes (CFRD). The lung function effects of CFRD are likely to be multifactorial with some mechanisms having greater influence in certain patients.

References

    1. Andersen DH. Cystic fibrosis of the pancreas and its relation to celiac disease: a clinical and pathologic study. Am J Dis Child 1938; 56: 344–399. doi:10.1001/archpedi.1938.01980140114013 - DOI
    1. Stephenson AL, Stanojevic S, Sykes J, et al. . The changing epidemiology and demography of cystic fibrosis. Presse Med 2017; 46(6 Pt 2): e87–e95. doi:10.1016/j.lpm.2017.04.012 - DOI - PubMed
    1. Lewis C, Blackman SM, Nelson A, et al. . Diabetes-related mortality in adults with cystic fibrosis. Role of genotype and sex. Am J Respir Crit Care Med 2015; 191: 194–200. doi:10.1164/rccm.201403-0576OC - DOI - PMC - PubMed
    1. Moran A, Dunitz J, Nathan B, et al. . Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care 2009; 32: 1626–1631. doi:10.2337/dc09-0586 - DOI - PMC - PubMed
    1. Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient Registry 2017 Annual Data Report. Bethesda, Maryland, Cystic Fibrosis Foundation, 2018.